Send to

Choose Destination
Compend Contin Educ Dent. 2018 Jun;39(6):355-361; quiz 362.

Sinus Augmentation Using Platelet-Rich Fibrin With or Without a Bone Graft: What Is the Consensus?

Author information

Adjunct Faculty, Department of Periodontology, Nova Southeastern University, Fort Lauderdale, Florida; Course Instructor, Advanced PRF Education.
Clinical Associate Professor, Departments of Periodontics and Prosthodontics, University of Florida College of Dentistry, Gainesville, Florida; Founder and CEO, Pikos Institute, Tampa, Florida; Private Practice, Oral and Maxillofacial Surgery, Palm Harbor, Florida.


Regenerative therapies with platelets have been widely used in medicine over the past two decades as a means to speed revascularization to damaged/defective tissues. Within the oral cavity, the sinus is one of the least vascularized areas with healing times typically increased to augment lost or missing bone. As a result, attempts have been proposed to combine platelet concentrates with various biomaterials to accelerate new blood flow to these tissues and ultimately facilitate new bone regeneration. While platelet-rich plasma (PRP) was introduced as a first-generation platelet concentrate, more recently platelet-rich fibrin (PRF) has been developed with anticoagulant removal from centrifugation protocols. Unlike PRP, PRF forms a fibrin clot that may further be utilized as a 3-dimensional scaffold containing a concentrated pool of autologous growth factors for tissue regeneration. Over the past decade, PRF has been used both as a sole grafting material and in combination with a bone graft for sinus augmentation procedures. This article highlights the biological and clinical advantages of using PRF with or without a bone grafting material for sinus augmentation procedures and provides guidelines detailing when, where, and why to use PRF alone versus in combination with a bone graft. Furthermore, the use of PRF for the repair of Schneiderian membrane perforations and as a barrier membrane for lateral window closure is discussed.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center